Dr. Paul Billings has devoted his life to studying and teaching medicine and genetics, while accelerating the use of a broad range of novel genomic technologies in clinical settings. As Chief Executive Officer, he leads strategy and growth for Biological Dynamics’ highly differentiated and proprietary platform for analyzing extracellular vesicles and exo-proteins to improve disease detection and management. Over decades in healthcare, he has established key business partnerships, driving adoption of innovative discoveries and commercial success. Dr. Billings has held academic appointments at Harvard, U.C. San Francisco, Stanford, and U.C. Berkeley; and served as board-certified internist and medical geneticist at leading medical centers. He has more than 225 biomedical citations and his published doctoral studies at Harvard were supervised by Dr. Baruj Benacerraf, who subsequently received the Nobel Prize in Medicine. He has served as Director or Advisor to numerous advisory boards and committees focused on medicine and genomic technologies.